Gender | |
- Male (n/total) | 10/40 (25%) |
- Female (n/total) | 30/40 (75%) |
Mean age (years) | 45 ± 15 |
ATA 2015 risk stratification | |
- Low (n/total) | 21/40 (52.5%) |
- Intermediate (n/total) | 15/40 (37.5%) |
- High (n/total) | 4/40 (10%) |
Mean tumour size (cm ± SD) | 2.4 ± 1.3 |
Lymph node dissection (n/total) | 10/40 (25%) |
T stage | |
- 1 (n/total) | 15/40 (37.5%) |
- 2 (n/total) | 13/40 (32.5%) |
- 3 (n/total) | 12/40 (30%) |
N stage | |
- 0 (n/total) | 35/40 (87.5%) |
- 1 (n/total) | 5/40 (12.5%) |
M stage | |
- 0 (n/total) | 40/40 (100%) |
- 1 (n/total) | 0/40 (0%) |
AJCC stagea (n/total) | |
- Stage 1 (n/total) | 28/40 (70%) |
- Stage 2 (n/total) | 9/40 (22.5%) |
- Stage 3 (n/total) | 3/40 (7.5%) |
- Stage 4 (n/total) | 0/40 (0%) |
Histology | |
- Papillary (n/total) | 36/40 (90%) |
- Follicular (n/total) | 4/40 (10%) |
Vascular invasion | |
- Yes (n/total) | 14/40 (35%) |
- No (n/total) | 26/40 (65%) |
Multifocal tumour | |
- Yes (n/total) | 13/40 (32.5%) |
- No (n/total) | 27/40 (77.5%) |
Microscopic positive margins | |
- Yes (n/total) | 14/40 (35%) |
- No (n/total) | 26/40 (75%) |
Post-ablation WBS | |
- Remnant (n/total) | 33/40 (82.5%) |
- Metastatic foci in the neck (n/total) | 7/40 (17.5%) |
- Distant foci (n/total) | 0/40 (0%) |